149. 片側痙攣・片麻痺・てんかん症候群 Hemiconvulsion hemiplegia epilepsy syndrome Clinical trials / Disease details


臨床試験数 : 25 薬物数 : 35 - (DrugBank : 13) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 22

  
6 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05615987
(ClinicalTrials.gov)
December 1, 20222/11/2022Comparison of Botulinum Toxin Injection Techniques in SpasticityComparison of the Efficacy of 2 Different Botulinum Toxin Injection Techniques in Gastrocnemius Muscle Spasticity in Hemiplegic Patients: A Randomized Double-blind Controlled Study.Spastic HemiplegiaDrug: Onabotulinumtoxina for InjectionKonya Beyhekim Training and Research HospitalNULLNot yet recruiting18 Years90 YearsAll60Phase 4Turkey
2NCT04630873
(ClinicalTrials.gov)
November 20, 202031/10/2020Low or High Botox Dilution for the Hemiplegic Gait?Different Dilutions and Efficacy of Botulin Toxin in the Correction of the Hemiplegic GaitPost Stroke Spastic HemiplegiaDrug: Botulinum toxin;Diagnostic Test: gait analysisUniversity of IoanninaNULLRecruiting18 YearsN/AAll20Phase 1Greece
3NCT03860662
(ClinicalTrials.gov)
May 26, 20188/2/2019The Effect of Oral Baclofen and Botulinum Toxin Treatments in Hemiplegic Spasticity on the Nociceptive Flexor ReflexDoctor, Physical Medicine and RehabilitationStroke Sequelae;Spastic HemiplegiaDiagnostic Test: Nociceptor flexor reflex;Drug: Botox;Drug: BaclofenMustafa Kemal UniversityNULLCompleted18 Years60 YearsAll29Phase 4Turkey
4ChiCTR-ICR-15007022
2014-05-012015-09-06A research of biomechanic stimulation and healing of hemiplegia gaitA research of biomechanic stimulation and healing of hemiplegia gait strokebotulinum toxin A type group:inject botulinum toxin A type;conventional treatment A group :conventional treatment;Dynamic electrical stimulation treatment group:Dynamic electrical stimulation;conventional treatment B group :conventional treatment;blank control group:null;validation group :botulinum toxin A type ;Nanjing Sports InstitudeNULLRecruiting4070Bothbotulinum toxin A type group:30;conventional treatment A group :30;Dynamic electrical stimulation treatment group:30;conventional treatment B group :30;blank control group:30;validation group :30;China
5EUCTR2009-015620-29-BE
(EUCTR)
08/03/201009/02/2010The efficacy of the Botulinum toxin-A on the manual abilities in children with congenital spastic hemiplegia. Interest of the measure of the bimanual task performance.The efficacy of the Botulinum toxin-A on the manual abilities in children with congenital spastic hemiplegia. Interest of the measure of the bimanual task performance. The main objective of this study is to investigate the effect of Botulinum toxin A to improve the Upper Limb dysfunction in Hemiplegic Cerebral Palsy Children and in particular, its impact on Upper limb activity performance and how this might be translate in bimanual activities.
MedDRA version: 12.0;Level: LLT;Classification code 10019475;Term: Hemiplegic infantile cerebral palsy
Trade Name: BOTOX
Product Name: BOTOX
Product Code: 9060X
Other descriptive name: BOTULINUM TOXIN TYPE A
NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
30Belgium
6NCT00276185
(ClinicalTrials.gov)
December 200512/1/2006HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After StrokeEffect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After StrokeHemiplegiaDrug: Time delay treatment of botulinum toxinUniversity Hospital, Clermont-FerrandJ. Rebeyrol Hospital in Limoges;Rennes University Hospital;Center of Physical Medicine and Rehabilitation (Notre Dame de Lourdes Center in Rennes);Saint Jacques Hospital in Nantes;Centre Hospitalier Universitaire de Saint Etienne;Centre Régional de Département de médecine physique et réadaptation CHU-C3RF in Angers;Centre Hospitalier Universitaire de BesanconRecruiting18 YearsN/ABoth180Phase 3France